Pfizer BioNTech vaccine documents hacked from European Medicines Agency
The Agency has swiftly launched a full investigation, in close cooperation with law enforcement and other relevant entities.
EMA cannot provide additional details whilst the investigation is ongoing. Further information will be made available in due course.
BioNTech, in a statement published on its website, said it had been told its documents had been accessed.
"We were informed by the European Medicines Agency (EMA) that the agency has been subject to a cyber attack and that some documents relating to the regulatory submission for Pfizer and BioNTech’s coronavirus vaccine candidate, BNT162b2, which has been stored on an EMA server, had been unlawfully accessed.
"It is important to note that no BioNTech or Pfizer systems have been breached in connection with this incident and we are unaware that any study participants have been identified through the data being accessed.
"At this time, we await further information about EMA’s investigation and will respond appropriately and in accordance with EU law. EMA has assured us that the cyber attack will have no impact on the timeline for its review, " BioNTech said. ■